Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast cancer outcome improved after primary systemic chemotherapy
May 10th, 2006
Breast cancer outcome might improve after primary systemic chemotherapy in patients who achieved a pathologic complete response (pCR) from metastases. According to recent research from the United States, "Breast carcinoma axillary lymph node (ALN) pCR after primary chemotherapy is associated with significantly higher recurrence-free survival (RFS) and overall survival (OS) rates. The purpose of the current study was to determine long-term outcome in patients achieving a pCR of cytologically proven inflammatory breast carcinoma ALN metastases after primary chemotherapy." "Patients with cytologically documented ALN metastases from inflammatory breast...
Source: Vaccine Weekly (2006-05-10)
|
